Skip to contentB
Boston Scientific Corp
B
BSXBoston Scientific Corp Source filing unavailable
Q1 2013 · —
Revenue$1.71B$1.71B−8.6% vs Q1 2012 Net Income-$354.00M-$354.00MN/M vs Q1 2012 EPS Diluted-$0.26-$0.26N/M vs Q1 2012 Gross Profit$1,183,000,000−4.2% Operating Income-$330,000,000N/M Operating Cash Flow$187,000,000
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Boston Scientific Corp · CIK 885725 · Engraved from SEC EDGAR
−11.8%
Free Cash Flowderived$134,000,000−8.2% Margins · derivedGross margin69.3%+3.2 pt vs Q1 2012
Operating margin-19.3%−29.8 pt vs Q1 2012
Net margin-20.8%−26.8 pt vs Q1 2012